Showing results (171-180 of 178) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.The Journal of Infectious Diseases|August 1, 1995
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsisT van der Poll, E Fischer, S M Coyle, et al.Blood|May 15, 1997
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansT van der Poll, S M Coyle, M Levi, et al.The Journal of Experimental Medicine|July 1, 1996
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboonM B Welborn, K Van Zee, P D Edwards, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081K J Van Zee, L L Moldawer, H S Oldenburg, et al.Journal of the American Academy of Dermatology|June 21, 2023
Performance measurement part I: Foundational knowledge for measure developmentTatiana Abrantes, Dillon Imbriano, Daniella Reimann, et al.Journal of the American Academy of Dermatology|June 21, 2023
Performance measurement part II: A guide to developing dermatology performance measuresDaniella Reimann, Dillon Imbriano, Tatiana Abrantes, et al.Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.Pageof 18